NCT04906681 is a Phase 1, PHASE2 clinical trial of i-ACT in Arthroplasty, sponsored by PXL University College.

Who is sponsoring NCT04906681?

NCT04906681 is sponsored by PXL University College.

What drugs are being tested in NCT04906681?

Interventions in NCT04906681: i-ACT.

What condition does NCT04906681 study?

NCT04906681 studies Arthroplasty, Neurologic Disorder.

Is NCT04906681 still recruiting?

NCT04906681 is currently status unknown. Last updated 1 June 2021.

Last reviewed 2021-06-01 · How we verify

NCT04906681

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study

Status unknown Phase 1, PHASE2 Last updated 1 June 2021

What this trial tests

Phase 1, PHASE2 trial testing i-ACT in Arthroplasty in 40 participants. Status unknown.

Timeline

1 September 2021

Primary endpoint
1 June 2022

1 July 2022

Quick facts

Lead sponsor	PXL University College
Phase	Phase 1, PHASE2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 September 2021
Primary completion	1 June 2022
Estimated completion	1 July 2022

Drugs / interventions tested

i-ACT

Conditions studied

Arthroplasty — all drugs for Arthroplasty →
Neurologic Disorder — all drugs for Neurologic Disorder →

Sponsor

PXL University College

Who can join

18 and older, any sex, with Arthroplasty or Neurologic Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rehabilitation technology is more and more implemented in conventional therapy to increase the dosage of therapy and/or increase patient's motivation towards therapy. In orthopedic as well as neurological rehabilitation it is important to exercise with enough intensity and repetitions to improve functional performance in activities of daily life, and consequently quality of life. At the moment, not all (rehabilitation) technologies are adapted towards the wishes and needs of both patients and therapists for everyday use in the clinical setting. Also, not all technologies are fit for independent use by the patients. Researcher of PXL have developed a Kinect-based system (i.e. i-ACT) for rehabilitation and performed supervised research with i-ACT in neurological and musculoskeletal rehabilitation, and older adults. Within this research, patients will exercise with i-ACT under supervision of their therapist during weekdays, but in the weekends they will be motivated by the medical staff to perform their exercises with i-ACT. The medical staff will be present for safety reasons, but the patient is asked to use and exercise with i-ACT as independent as possible. The aim of this research is to explore to which extend i-ACT is suitable for semi-independent use by patients in orthopedic or neurological rehabilitation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of i-ACT

Trials testing the same drug.

NCT04489563 — Feasibility Study of i-ACT in Aged Persons · NA · completed
NCT02982811 — Intelligent Activity-based Client-centred Training · NA · completed

Other recruiting trials for Arthroplasty

Currently open trials in the same condition.

NCT07425457 — Cryoneurolysis Prior to Total Knee Arthroplasty (CRYO-TKA Trial) · NA · recruiting
NCT06323980 — INHANCE Stemless Reverse Shoulder IDE · NA · recruiting
NCT04848896 — Study to Evaluate the Safety and Effectiveness of the REAL INTELLIGENCE™ CORI™ in Total Knee Arthroplasty (TKA) Procedur · NA · recruiting
NCT04849884 — To Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System. · NA · active not recruiting
NCT05190666 — Healthy Living After Knee Replacement · NA · active not recruiting

Other PXL University College trials

Trials by the same sponsor.

NCT07431996 — Back to Work: Perspective of the Employee (Original Language Dutch: Terug-naar-werk: Perspectief Van Werknemer) · not yet recruiting
NCT06094374 — Unveiling the Digital Phenotype of PA Behavior · unknown
NCT05650515 — A Technology-based Exercise Program for Older Adults · unknown
NCT05234151 — The Newborn Early Warning System · unknown
NCT06157190 — Incorporating Wearable Technology for Enhanced Rehabilitation Monitoring After Hip and Knee Replacement · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04906681 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PXL University College
Last refreshed: 1 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04906681.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing